Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raj Sengupta

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
The Lancet. Rheumatology|June 28, 2024
Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trialClaudia Worth, M Hussein Al-Mossawi, Joanne Macdonald, et al.
Rheumatology Advances in Practice|May 17, 2023
Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeSizheng Steven Zhao, Stephanie R Harrison, Antoni Chan, et al.
Rheumatology (Oxford, England)|May 3, 2019
Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UKTimothy J P Bray, Alexis Jones, Alexander N Bennett, et al.
Annals of the Rheumatic Diseases|June 15, 2023
ASAS consensus definition of early axial spondyloarthritisVictoria Navarro-Compán, Diego Benavent, Dafne Capelusnik, et al.
Rheumatology (Oxford, England)|April 8, 2025
The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Rheumatology (Oxford, England)|April 8, 2025
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
The Lancet. Rheumatology|June 28, 2024
Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trialClaudia Worth, M Hussein Al-Mossawi, Joanne Macdonald, et al.
Rheumatology Advances in Practice|May 17, 2023
Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeSizheng Steven Zhao, Stephanie R Harrison, Antoni Chan, et al.
Rheumatology (Oxford, England)|May 3, 2019
Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UKTimothy J P Bray, Alexis Jones, Alexander N Bennett, et al.
Annals of the Rheumatic Diseases|June 15, 2023
ASAS consensus definition of early axial spondyloarthritisVictoria Navarro-Compán, Diego Benavent, Dafne Capelusnik, et al.
Rheumatology (Oxford, England)|April 8, 2025
The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Rheumatology (Oxford, England)|April 8, 2025
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Pageof 9